Schedule 13D ownership disclosure

OncBioMune Pharmaceuticals, Inc

Security class unavailable

Event date: 2015-08-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
3.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-15-004349
Form type
SC 13D/A
Filer
Leone Group, LLC
CIK
CIK 1642323
Filed
Sep 15, 2015
Reporting period
Aug 27, 2015
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub